Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms
- PMID: 34312902
- PMCID: PMC7614658
- DOI: 10.1002/sim.9135
Optimal design of cluster randomized trials allowing unequal allocation of clusters and unequal cluster size between arms
Abstract
There are sometimes cost, scientific, or logistical reasons to allocate individuals unequally in an individually randomized trial. In cluster randomized trials we can allocate clusters unequally and/or allow different cluster size between trial arms. We consider parallel group designs with a continuous outcome, and optimal designs that require the smallest number of individuals to be measured given the number of clusters. Previous authors have derived the optimal allocation ratio for clusters under different variance and/or intracluster correlations (ICCs) between arms, allowing different but prespecified cluster sizes by arm. We derive closed-form expressions to identify the optimal proportions of clusters and of individuals measured for each arm, thereby defining optimal cluster sizes, when cluster size can be chosen freely. When ICCs differ between arms but the variance is equal, the optimal design allocates more than half the clusters to the arm with the higher ICC, but (typically only slightly) less than half the individuals and hence a smaller cluster size. We also describe optimal design under constraints on the number of clusters or cluster size in one or both arms. This methodology allows trialists to consider a range for the number of clusters in the trial and for each to identify the optimal design. Except if there is clear prior evidence for the ICC and variance by arm, a range of values will need to be considered. Researchers should choose a design with adequate power across the range, while also keeping enough clusters in each arm to permit the intended analysis method.
Keywords: cluster randomized trial; optimal design; power; sample size; unequal allocation.
© 2021 The Authors. Statistics in Medicine published by John Wiley & Sons Ltd.
Figures



Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.Stat Med. 2023 Aug 30;42(19):3392-3412. doi: 10.1002/sim.9811. Epub 2023 Jun 14. Stat Med. 2023. PMID: 37316956
-
Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.Clin Trials. 2022 Feb;19(1):42-51. doi: 10.1177/17407745211059845. Epub 2021 Dec 8. Clin Trials. 2022. PMID: 34879711 Free PMC article.
-
Appropriate statistical methods for analysing partially nested randomised controlled trials with continuous outcomes: a simulation study.BMC Med Res Methodol. 2018 Oct 11;18(1):105. doi: 10.1186/s12874-018-0559-x. BMC Med Res Methodol. 2018. PMID: 30314463 Free PMC article.
-
Methods for dealing with unequal cluster sizes in cluster randomized trials: A scoping review.PLoS One. 2021 Jul 29;16(7):e0255389. doi: 10.1371/journal.pone.0255389. eCollection 2021. PLoS One. 2021. PMID: 34324593 Free PMC article.
Cited by
-
Key considerations for designing, conducting and analysing a cluster randomized trial.Int J Epidemiol. 2023 Oct 5;52(5):1648-1658. doi: 10.1093/ije/dyad064. Int J Epidemiol. 2023. PMID: 37203433 Free PMC article.
-
Cluster Randomized Trials Designed to Support Generalizable Inferences.Eval Rev. 2024 Dec;48(6):1088-1114. doi: 10.1177/0193841X231169557. Epub 2024 Jan 17. Eval Rev. 2024. PMID: 38234059
-
Power analysis for concurrent balanced or imbalanced multiple-intervention stepped wedge design: a simulation-based approach.BMC Med Res Methodol. 2025 Apr 16;25(1):96. doi: 10.1186/s12874-025-02546-w. BMC Med Res Methodol. 2025. PMID: 40241012 Free PMC article.
-
How Should Parallel Cluster Randomized Trials With a Baseline Period be Analyzed?-A Survey of Estimands and Common Estimators.Biom J. 2025 Jun;67(3):e70052. doi: 10.1002/bimj.70052. Biom J. 2025. PMID: 40302411 Free PMC article.
References
-
- Gail M, Williams R, Byar DP, Brown C. How many controls? J Chron Dis. 1976;29:723–731. - PubMed
-
- Roberts C, Roberts SA. Design and analysis of clinical trials with clustering effects due to treatment. Clinical Trials. 2005;2:152–162. - PubMed
-
- Candel MJJM, Van Breukelen GJP. Sample size calculation for treatment effects in randomized trials with fixed cluster sizes and heterogeneous intraclass correlations and variances. Stat Meth Med Res. 2015;24(5):557–573. - PubMed
-
- Moerbeek M, Wong WK. Sample size formulae for trials comparing group and individual treatments in a multilevel model. Stat Med. 2008;27:2850–2864. - PubMed
-
- Perkins GD, Lall R, Quinn T, et al. Mechanical versus manual chest compression for out-of-hospital cardiac arrest (PARAMEDIC): a pragmatic, cluster randomised controlled trial. Lancet. 2015;385:947–955. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources